Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
SLXN	SILEXION THERAPEUTICS CORP	$8.79M	-1,666.00%	-331.90%	-267.26%	-838.50%	0.67	3.97	N/A	N/A	N/A
ALMS	ALUMIS INC	$1.20B	-75.50%	-57.60%	-60.04%	-105.60%	0.27	6.01	100.00%	-1,108.20%	-1,146.94%
PALI	PALISADE BIO INC	$289.07M	-240.70%	-137.30%	-320.89%	577.10%	1.17	1.96	N/A	N/A	N/A
SPRB	SPRUCE BIOSCIENCES INC	$89.27M	-305.40%	-168.00%	-762.62%	955.90%	1.84	1.54	100.00%	-6,869.30%	-6,440.17%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$233.66M	-33.30%	-28.40%	-32.73%	-29.60%	0.19	14.96	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$498.55M	-25.70%	-24.80%	-13.73%	-155.60%	0.02	56.10	N/A	N/A	N/A
SAVA	CASSAVA SCIENCES INC	$141.54M	-95.80%	-75.30%	-129.80%	2,002.20%	0.59	2.27	N/A	N/A	N/A
RARE	ULTRAGENYX PHARMACEUTICAL INC	$3.50B	-436.00%	-43.70%	-67.82%	-38.30%	543.90	1.89	84.70%	-91.90%	-91.46%
LTRN	LANTERN PHARMA INC	$40.26M	-126.00%	-97.40%	-197.36%	-232.80%	0.42	3.33	N/A	N/A	N/A
HYFT	MINDWALK HOLDINGS CORP	$81.69M	-114.30%	-61.20%	-134.12%	-119.00%	0.96	2.17	56.70%	-130.20%	-143.91%
KYMR	KYMERA THERAPEUTICS INC	$6.45B	-33.40%	-28.60%	-28.61%	-33.60%	0.17	7.38	100.00%	-674.80%	-674.04%
TAOX	TAO SYNERGIES INC	$42.92M	-244.20%	-152.10%	-153.61%	-540.70%	0.11	17.61	100.00%	-13,058.70%	-12,829.93%
TPST	TEMPEST THERAPEUTICS INC	$13.81M	-310.90%	-125.10%	-261.69%	-289.60%	1.70	2.30	N/A	N/A	N/A
KPTI	KARYOPHARM THERAPEUTICS INC	$118.50M	N/A	-101.10%	-883.59%	-45.00%	-1.36	1.03	95.90%	-87.40%	-56.26%
CVM	CEL SCI CORP	$43.77M	-259.40%	-107.20%	-167.96%	-105.40%	1.90	0.47	N/A	N/A	N/A
EPRX	EUPRAXIA PHARMACEUTICALS INC	$225.47M	-67.40%	-65.30%	-33.21%	20,901.30%	0.04	23.98	N/A	N/A	N/A
PTGX	PROTAGONIST THERAPEUTICS INC	$5.96B	6.90%	6.30%	7.32%	8.50%	0.09	13.05	100.00%	21.90%	22.98%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$23.10M	-219.00%	-178.10%	-82.92%	-1,205.80%	0.11	10.42	N/A	N/A	N/A
ESLA	ESTRELLA IMMUNOPHARMA INC	$65.33M	N/A	-446.70%	137.24%	246.60%	-1.36	0.15	N/A	N/A	N/A
CGEM	CULLINAN THERAPEUTICS INC	$704.19M	-42.10%	-39.80%	-48.01%	-49.30%	0.07	10.45	N/A	N/A	N/A
WVE	WAVE LIFE SCIENCES LTD	$2.77B	-75.60%	-43.00%	-78.43%	504.40%	0.88	2.51	100.00%	-111.60%	-111.64%
IRD	OPUS GENETICS INC	$162.76M	-774.20%	-170.70%	-968.51%	467.50%	5.05	1.24	100.00%	-466.10%	-465.63%
INMB	INMUNE BIO INC	$53.44M	-172.00%	-134.50%	-191.87%	1,346.60%	0.31	4.17	100.00%	-99,774.00%	-99,774.00%
THAR	THARIMMUNE INC	$83.76M	-588.40%	-264.40%	-167.25%	641.10%	0.25	4.99	N/A	N/A	N/A
RCUS	ARCUS BIOSCIENCES INC	$2.32B	-68.20%	-31.30%	-44.93%	-44.90%	1.23	3.65	100.00%	-142.10%	-138.33%
EVMN	EVOMMUNE INC	$567.75M	N/A	N/A	N/A	N/A	-0.06	7.87	N/A	N/A	N/A
MAZE	MAZE THERAPEUTICS INC	$1.87B	-65.20%	-31.20%	-31.61%	-208.60%	0.11	17.70	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$267.74M	-102.10%	-74.40%	-114.78%	-85.40%	0.54	4.29	100.00%	-3,442.80%	-3,509.47%
GOSS	GOSSAMER BIO INC	$833.24M	N/A	-59.70%	-100.61%	-38.50%	-3.54	3.28	100.00%	-354.50%	-335.05%
RAPP	RAPPORT THERAPEUTICS INC	$1.44B	-28.60%	-27.20%	-18.75%	-38.90%	0.05	36.37	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$405.67M	-45.90%	-44.00%	-41.64%	2,647.30%	0.03	46.95	N/A	N/A	N/A
KALV	KALVISTA PHARMACEUTICALS INC	$854.74M	N/A	N/A	N/A	N/A	19.00	7.22	N/A	N/A	N/A
STOK	STOKE THERAPEUTICS INC	$1.85B	13.30%	11.40%	8.62%	16.40%	0.17	6.53	100.00%	19.70%	13.35%
TLSA	TIZIANA LIFE SCIENCES LTD	$198.40M	-250.50%	-101.10%	-425.46%	-666.20%	1.87	1.02	N/A	N/A	N/A
TYRA	TYRA BIOSCIENCES INC	$1.21B	-35.80%	-33.60%	-39.05%	-47.60%	0.08	17.71	N/A	N/A	N/A
SLRX	SALARIUS PHARMACEUTICALS INC	$4.57M	-401.00%	-155.80%	-117.81%	443.70%	0.44	3.28	N/A	N/A	N/A
ACXP	ACURX PHARMACEUTICALS INC	$8.49M	-362.10%	-175.30%	-252.13%	359.90%	0.68	2.47	N/A	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$1.44B	-68.90%	-61.50%	-44.49%	-128.50%	0.09	13.70	100.00%	22,448.40%	22,543.91%
GNLX	GENELUX CORP	$164.00M	-129.30%	-97.40%	-160.49%	-169.50%	0.34	4.20	N/A	N/A	N/A
PTHS	PELTHOS THERAPEUTICS INC	$70.39M	-210.30%	-72.80%	-21.88%	-431.20%	1.17	2.01	68.70%	-318.40%	-300.30%
NTLA	INTELLIA THERAPEUTICS INC	$1.04B	-57.20%	-44.60%	-53.61%	-51.60%	0.24	6.21	100.00%	-774.90%	-774.94%
TSHA	TAYSHA GENE THERAPIES INC	$1.59B	-67.30%	-42.10%	-34.68%	-185.10%	0.45	10.48	100.00%	-1,583.70%	-1,582.50%
TERN	TERNS PHARMACEUTICALS INC	$4.05B	-30.00%	-28.50%	-32.91%	-55.60%	0.06	19.52	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$153.25M	15.30%	3.60%	4.46%	3.60%	2.28	2.30	100.00%	1,536.80%	1,536.75%
EWTX	EDGEWISE THERAPEUTICS INC	$2.50B	-30.90%	-29.40%	-27.99%	-33.30%	0.04	26.51	N/A	N/A	N/A
PLRX	PLIANT THERAPEUTICS INC	$75.58M	-71.50%	-53.30%	-66.51%	-62.10%	0.38	13.94	N/A	N/A	N/A
INKT	MINK THERAPEUTICS INC	$58.30M	N/A	-180.10%	-807.47%	238.30%	-2.11	1.08	N/A	N/A	N/A
IMRX	IMMUNEERING CORP	$392.59M	-73.50%	-65.00%	-26.99%	-1,472.40%	0.06	24.00	N/A	N/A	N/A
ALLO	ALLOGENE THERAPEUTICS INC	$339.34M	-57.80%	-43.10%	-51.66%	-53.00%	0.40	8.19	N/A	N/A	N/A
IMNM	IMMUNOME INC	$1.79B	-87.20%	-75.60%	-83.13%	-373.20%	0.13	8.90	100.00%	-2,301.30%	-2,301.30%
NNVC	NANOVIRICIDES INC	$22.50M	-95.80%	-83.80%	-113.25%	-138.60%	0.17	1.06	N/A	N/A	N/A
ELVN	ENLIVEN THERAPEUTICS INC	$1.00B	-24.90%	-24.00%	-20.41%	-34.80%	0.03	32.95	N/A	N/A	N/A
OMER	OMEROS CORP	$719.64M	N/A	-53.90%	-121.65%	-23.80%	-1.84	0.89	N/A	N/A	N/A
LENZ	LENZ THERAPEUTICS INC	$567.60M	-29.60%	-27.90%	-30.03%	-33.60%	0.09	12.69	100.00%	-336.50%	-333.61%
KYTX	KYVERNA THERAPEUTICS INC	$384.53M	-77.90%	-65.80%	-104.98%	-103.60%	0.23	5.16	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$664.84M	N/A	-18.10%	-20.87%	-24.90%	-0.03	10.32	100.00%	-9,547.40%	-9,049.33%
TLX	TELIX PHARMACEUTICALS LTD	$3.02B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
GPCR	STRUCTURE THERAPEUTICS INC	$4.06B	-26.10%	-24.70%	-27.14%	-31.10%	0.08	14.15	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$237.40M	-263.50%	-120.00%	-254.88%	547.00%	1.43	1.53	N/A	N/A	N/A
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$5.55M	-88.90%	-85.20%	-106.61%	3,830.80%	0.05	20.71	60.00%	-99,356.80%	-99,356.80%
SION	SIONNA THERAPEUTICS INC	$1.91B	-33.40%	-22.70%	-21.45%	-27.40%	0.06	25.61	N/A	N/A	N/A
HUMA	HUMACYTE INC	$245.33M	N/A	-27.90%	-39.90%	-24.80%	-20.26	1.62	60.50%	-2,353.20%	-1,674.35%
IMMP	IMMUTEP LTD	$376.78M	-36.90%	-34.30%	-42.57%	-130.80%	0.09	11.69	100.00%	-594.60%	-594.28%
GLPG	GALAPAGOS NV	$2.09B	-16.20%	-11.30%	-14.48%	-14.00%	0.44	8.63	71.10%	-151.40%	-158.11%
ABCL	ABCELLERA BIOLOGICS INC	$1.08B	-17.00%	-12.60%	-15.92%	-17.70%	0.41	10.10	100.00%	-486.00%	-580.13%
ABVX	ABIVAX SA	$7.96B	-499.80%	-96.70%	-2,429.06%	-391.00%	-3.48	0.77	100.00%	-2,530.60%	-2,293.15%
DSGN	DESIGN THERAPEUTICS INC	$537.17M	-30.60%	-29.20%	-33.62%	-32.80%	0.06	18.71	N/A	N/A	N/A
VNDA	VANDA PHARMACEUTICALS INC	$368.17M	-16.80%	-13.40%	-22.17%	-33.30%	0.29	3.12	94.40%	-39.70%	-50.52%
ARMP	ARMATA PHARMACEUTICALS INC	$214.35M	N/A	-54.50%	63.18%	-29.50%	-1.94	0.12	100.00%	-3,797.70%	-2,580.16%
COGT	COGENT BIOSCIENCES INC	$6.00B	-126.20%	-89.70%	-80.45%	-153.00%	0.41	6.38	N/A	N/A	N/A
APLM	APOLLOMICS INC	$17.71M	-233.70%	-157.30%	-937.36%	2,070.90%	1.69	1.39	N/A	N/A	N/A
LEXX	LEXARIA BIOSCIENCE CORP	$29.78M	-187.00%	-162.00%	-443.82%	-2,392.90%	0.53	2.32	99.60%	-1,686.00%	-1,686.00%
VALN	VALNEVA SE	$704.80M	-58.90%	-21.50%	-24.13%	-19.10%	1.98	1.78	45.40%	-56.80%	-39.94%
LNAI	LUNAI BIOWORKS INC	$25.07M	-385.10%	-214.50%	1,021.63%	738.00%	-1.53	0.04	N/A	N/A	N/A
DYN	DYNE THERAPEUTICS INC	$2.75B	-66.20%	-56.30%	-52.13%	-146.40%	0.25	13.47	N/A	N/A	N/A
CLNN	CLENE INC	$69.96M	N/A	-125.60%	-200.24%	-105.20%	-2.81	1.53	82.20%	-14,250.50%	-13,104.67%
CELC	CELCUITY INC	$4.87B	-179.00%	-58.00%	-33.96%	-41.30%	3.07	12.26	N/A	N/A	N/A
KRRO	KORRO BIO INC	$77.50M	-68.90%	-45.90%	-60.11%	-49.60%	0.63	6.71	100.00%	-1,199.50%	-1,198.11%
MPLT	MAPLIGHT THERAPEUTICS INC	$939.22M	N/A	N/A	N/A	N/A	-0.09	13.22	N/A	N/A	N/A
TELO	TELOMIR PHARMACEUTICALS INC	$49.85M	-566.60%	-447.90%	-161.29%	2,487.30%	0.06	17.51	N/A	N/A	N/A
GANX	GAIN THERAPEUTICS INC	$149.44M	-341.30%	-174.10%	-266.08%	1,085.50%	0.86	2.52	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$339.39M	-32.30%	-30.30%	-32.19%	-35.60%	0.06	29.07	N/A	N/A	N/A
ABOS	ACUMEN PHARMACEUTICALS INC	$129.63M	-97.40%	-70.40%	-107.41%	-81.60%	0.53	6.02	N/A	N/A	N/A
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$76.51M	-20,541.50%	-187.50%	-494.36%	222.10%	2.15	1.39	N/A	N/A	N/A
BCYC	BICYCLE THERAPEUTICS PLC	$516.79M	-35.50%	-29.20%	-36.37%	-763.20%	0.24	10.66	100.00%	-884.50%	-891.54%
FDMT	4D MOLECULAR THERAPEUTICS INC	$619.34M	-47.30%	-42.40%	-54.07%	-54.60%	0.15	8.42	100.00%	-174,314.20%	-174,314.17%
LCTX	LINEAGE CELL THERAPEUTICS INC	$382.34M	-118.80%	-66.80%	-84.30%	3,452.30%	3.12	4.50	97.80%	-625.50%	-625.53%
RNTX	REIN THERAPEUTICS INC	$40.74M	-118.70%	-102.00%	-125.99%	1,317.70%	0.16	0.90	N/A	N/A	N/A
ALEC	ALECTOR INC	$162.64M	-123.00%	-27.50%	-42.18%	-38.10%	4.81	3.76	100.00%	-156.00%	-155.96%
ELTX	ELICIO THERAPEUTICS INC	$143.15M	-5,657.90%	-160.70%	-205.92%	-320.10%	6.41	3.30	N/A	N/A	N/A
ORKA	ORUKA THERAPEUTICS INC	$1.46B	-25.80%	-24.80%	-20.81%	-31.60%	0.05	16.94	N/A	N/A	N/A
IOBT	IO BIOTECH INC	$58.13M	-465.40%	-180.60%	-407.32%	5,856.20%	42.86	2.01	N/A	N/A	N/A
ACRV	ACRIVON THERAPEUTICS INC	$79.83M	-53.70%	-48.30%	-62.69%	-69.00%	0.13	8.75	N/A	N/A	N/A
HURA	TUHURA BIOSCIENCES INC	$52.54M	-221.90%	-141.90%	-178.58%	-2,355.40%	0.53	0.40	N/A	N/A	N/A
PGEN	PRECIGEN INC	$1.31B	-5,766.20%	-311.30%	-176.76%	-238.60%	3.09	4.04	30.30%	-6,750.10%	-3,899.94%
DTIL	PRECISION BIOSCIENCES INC	$66.15M	-213.80%	-72.20%	-104.61%	-207.20%	4.62	3.45	100.00%	-11,977.40%	-11,767.34%
MIST	MILESTONE PHARMACEUTICALS INC	$205.26M	-2,372.70%	-85.10%	-70.24%	-73.30%	3.28	8.24	N/A	N/A	N/A
PRAX	PRAXIS PRECISION MEDICINES INC	$6.72B	-66.90%	-60.30%	-79.49%	-115.20%	0.15	5.18	100.00%	-3,658.50%	-3,658.53%
XFOR	X4 PHARMACEUTICALS INC	$341.88M	-343.70%	-69.80%	-61.27%	-78.30%	1.65	5.65	83.20%	-279.90%	-252.51%
QCLS	Q/C TECHNOLOGIES INC	$19.88M	-121.40%	-48.90%	-25.40%	-419.50%	1.11	1.71	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #1 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 53, which is 30 points higher than the biotech industry average of 23.

ONC passed 18 out of 33 due diligence checks and has strong fundamentals. Beone Medicines has seen its stock return 76.99% over the past year, overperforming other biotech stocks by 122 percentage points.

Beone Medicines has an average 1 year price target of $390.88, an upside of 22.51% from Beone Medicines's current stock price of $319.06.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Beone Medicines, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: C, Momentum: B, Sentiment: B, Safety: C, Financials: A, and AI: B.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 46, which is 23 points higher than the biotech industry average of 23.

AUPH passed 15 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 63.57% over the past year, overperforming other biotech stocks by 109 percentage points.

Aurinia Pharmaceuticals has an average 1 year price target of $17.25, an upside of 8.83% from Aurinia Pharmaceuticals's current stock price of $15.85.

Aurinia Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Aurinia Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the #3 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Innoviva (NASDAQ:INVA) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Innoviva (NASDAQ:INVA) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

INVA passed 14 out of 33 due diligence checks and has strong fundamentals. Innoviva has seen its stock return 11.21% over the past year, overperforming other biotech stocks by 56 percentage points.

Innoviva has an average 1 year price target of $32.00, an upside of 55.11% from Innoviva's current stock price of $20.63.

Innoviva stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Innoviva, 25% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 25% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 12.13%, which is 9 percentage points higher than the biotech industry average of 2.94%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.29%, which is -1 percentage points lower than the biotech industry average of 2.94%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.55%, which is -2 percentage points lower than the biotech industry average of 2.94%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 64% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.42% in the last day, and up 0.28% over the last week. Sonnet Biotherapeutics Holdings was the among the top losers in the biotechnology industry, dropping -59.35% yesterday.

Sonnet BioTherapeutics Holdings shares are trading lower after the company announced its stockholders approved a business combination with Hyperliquid Strategies and Rorschach I.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 27.15% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 100.68% in the past year. It has overperformed other stocks in the biotech industry by 146 percentage points.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has gained 11.21% in the past year. It has overperformed other stocks in the biotech industry by 56 percentage points.

Are biotech stocks a good buy now?

59.96% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 47.99% over the next year.

3.31% of biotech stocks have a Zen Rating of A (Strong Buy), 6.42% of biotech stocks are rated B (Buy), 44.93% are rated C (Hold), 32.3% are rated D (Sell), and 13.04% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 155.66x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Beone Medicines (NASDAQ:ONC)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Innoviva (NASDAQ:INVA)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Beone Medicines (NASDAQ:ONC)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Innoviva (NASDAQ:INVA)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.